At the end of the latest market close, Allena Pharmaceuticals Inc. (ALNA) was valued at $0.48. In that particular session, Stock kicked-off at the price of $0.5065 while reaching the peak value of $0.5074 and lowest value recorded on the day was $0.475. The stock current value is $0.48.Recently in News on January 4, 2022, Allena Pharmaceuticals Provides Clinical and Corporate Update. ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in first cohort of patients with hyperuricemia and chronic kidney disease in the Phase 2a Study 201. You can read further details here
Allena Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.7720 on 01/04/22, with the lowest value was $0.4630 for the same time period, recorded on 01/06/22.
Allena Pharmaceuticals Inc. (ALNA) full year performance was -67.85%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Allena Pharmaceuticals Inc. shares are logging -82.84% during the 52-week period from high price, and 3.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.46 and $2.78.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 691921 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Allena Pharmaceuticals Inc. (ALNA) recorded performance in the market was -19.16%, having the revenues showcasing -46.01% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 36.98M, as it employees total of 35 workers.
Specialists analysis on Allena Pharmaceuticals Inc. (ALNA)
During the last month, 0 analysts gave the Allena Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8107, with a change in the price was noted -0.44. In a similar fashion, Allena Pharmaceuticals Inc. posted a movement of -47.74% for the period of last 100 days, recording 2,877,649 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALNA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.38.
Trends and Technical analysis: Allena Pharmaceuticals Inc. (ALNA)
Raw Stochastic average of Allena Pharmaceuticals Inc. in the period of last 50 days is set at 2.40%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.50%. In the last 20 days, the company’s Stochastic %K was 5.93% and its Stochastic %D was recorded 7.31%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -19.16%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -45.43%, alongside a downfall of -67.85% for the period of the last 12 months. The shares increased approximately by -5.04% in the 7-day charts and went up by -24.00% in the period of the last 30 days. Common stock shares were lifted by -46.01% during last recorded quarter.